Patent details

Basic Information

Publication number:

EP4429693

PCT Application Number:

EP2023063441

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP237307186

PCT Publication Number:

WO2023227468

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MONOMERIC ANNEXIN A5 FOR USE IN THE TREATMENT OF MACULAR OEDEMA OR RETINAL VEIN OCCLUSION

French Title of Invention:

ANNEXINE A5 MONOMÈRE POUR UNE UTILISATION DANS LE TRAITEMENT DE L'OEDÈME MACULAIRE OU D'UNE OCCLUSION D'UNE VEINE RÉTINIENNE

German Title of Invention:

MONOMERES ANNEXIN A5 ZUR VERWENDUNG BEI DER BEHANDLUNG VON MAKULAÖDEMEN ODER NETZHAUTVENENOKKLUSION

SPC Number:

Dates

Filing date:

18/05/2023

Grant date:

26/02/2025

EP Publication Date:

18/09/2024

PCT Publication Date:

30/11/2023

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/02/2025

EP B1 Publication Date:

26/02/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/05/2025

Expiration date:

18/05/2043

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/02/2025

 

 

Name:

Annexin Pharmaceuticals AB

Address:

Kammakargatan 48, 111 60 Stockholm, Sweden (SE)

Inventor

1

Name:

FROSTEGÅRD, Anna

Address:

Sweden (SE)

2

Name:

HAEGERSTRAND, Anders

Address:

Sweden (SE)

Priority

Priority Number:

202207263

Priority Date:

18/05/2022

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 38/17; A61P 27/02;

Publication

European Patent Bulletin

Issue number:

202509

Publication date:

26/02/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages